Marc G Caron Selected Research

Protein Phosphatase 2 (Protein Phosphatase 2A)

12/2012	Deletion of GSK3β in D2R-expressing neurons reveals distinct roles for β-arrestin signaling in antipsychotic and lithium action.
1/2008	A beta-arrestin 2 signaling complex mediates lithium action on behavior.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marc G Caron Research Topics

Disease

20	Schizophrenia (Dementia Praecox) 01/2017 - 07/2003
13	Parkinson Disease (Parkinson's Disease) 11/2023 - 05/2002
11	Mental Disorders (Mental Disorder) 11/2020 - 07/2004
6	Neoplasms (Cancer) 10/2021 - 01/2013
6	Bipolar Disorder (Manic Depressive Psychosis) 01/2009 - 01/2007
5	Dyskinesias (Dyskinesia) 11/2023 - 09/2003
4	Catalepsy 02/2016 - 09/2011
4	Pain (Aches) 12/2013 - 12/2002
4	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2013 - 04/2004
3	Obesity 01/2019 - 10/2009
3	Neuralgia (Stump Neuralgia) 01/2017 - 05/2004
3	Inflammation (Inflammations) 01/2011 - 05/2004
2	Opioid-Related Disorders (Opiate Addiction) 01/2023 - 12/2022
2	Carcinogenesis 10/2021 - 07/2014
2	Substance-Related Disorders (Drug Abuse) 11/2020 - 11/2014
2	Cognitive Dysfunction 01/2020 - 06/2009
2	Insulin Resistance 08/2017 - 01/2017
2	Treatment-Resistant Depressive Disorder 11/2016 - 01/2016
2	Anxiety Disorders (Anxiety Disorder) 02/2015 - 01/2008
2	Mania (Manias) 02/2015 - 12/2012
2	Alzheimer Disease (Alzheimer's Disease) 01/2009 - 10/2008
2	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2008 - 09/2003
2	Tremor (Tremors) 10/2006 - 08/2005
1	Breast Neoplasms (Breast Cancer) 10/2021
1	Constipation 01/2019
1	Hydrops Fetalis (Fetal Edema) 01/2018
1	Ischemia 01/2018
1	Type 2 Diabetes Mellitus (MODY) 08/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2017
1	Osteoporosis 01/2017
1	Tobacco Use Disorder (Nicotine Dependence) 01/2017
1	Neurobehavioral Manifestations 01/2017
1	Lung Neoplasms (Lung Cancer) 01/2017
1	Postpartum Depression (Post-Natal Depression) 03/2015
1	Diabetes Insipidus 01/2015
1	Nervous System Diseases (Neurological Disorders) 01/2015
1	Hypersensitivity (Allergy) 09/2014
1	Anhedonia 02/2014
1	Hypothermia 05/2013

Drug/Important Bio-Agent (IBA)

22	Dopamine (Intropin)FDA LinkGeneric 11/2023 - 06/2002
10	Antipsychotic Agents (Antipsychotics)IBA 01/2017 - 07/2005
8	Serotonin (5 Hydroxytryptamine)IBA 01/2019 - 07/2004
7	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2018 - 01/2004
5	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 11/2023 - 09/2003
5	Dopamine Receptors (Dopamine Receptor)IBA 01/2019 - 07/2005
5	GTP-Binding Proteins (G-Protein)IBA 01/2019 - 10/2002
5	LithiumIBA 02/2015 - 04/2004
4	Proteins (Proteins, Gene)FDA Link 04/2011 - 11/2004
3	Dichlorodiphenyldichloroethane (DDD)IBA 11/2023 - 10/2006
3	Levodopa (L Dopa)FDA LinkGeneric 11/2023 - 01/2012
3	Haloperidol (Haldol)FDA LinkGeneric 02/2016 - 09/2011
3	LigandsIBA 02/2016 - 10/2010
3	Glutamic Acid (Glutamate)FDA Link 06/2009 - 11/2004
3	beta-Arrestin 2IBA 01/2009 - 07/2005
2	Opioid Analgesics (Opioids)IBA 01/2023 - 05/2004
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2020 - 06/2009
2	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 01/2017 - 02/2016
2	5-Hydroxytryptophan (5 Hydroxytryptophan)IBA 11/2016 - 01/2016
2	Antidepressive Agents (Antidepressants)IBA 01/2016 - 03/2013
2	Therapeutic UsesIBA 05/2015 - 10/2006
2	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 01/2015 - 10/2002
2	Arginine (L-Arginine)FDA Link 01/2015 - 10/2002
2	Amphetamine (Amfetamine)FDA LinkGeneric 01/2013 - 04/2010
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2013 - 11/2004
2	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 12/2012 - 01/2008
2	Cholinergic Agents (Cholinergics)IBA 11/2011 - 04/2010
2	Psychotropic Drugs (Psychoactive Drugs)IBA 01/2009 - 10/2008
2	Glycogen Synthase Kinase 3IBA 01/2008 - 04/2004
2	ChemokinesIBA 04/2005 - 05/2004
2	Morphine (MS Contin)FDA LinkGeneric 01/2004 - 12/2002
2	beta-ArrestinsIBA 01/2004 - 10/2002
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	Protein Isoforms (Isoforms)IBA 10/2021
1	Neurotensin Receptors (Neurotensin Receptor)IBA 11/2020
1	Glycogen Synthase (Synthase I)IBA 01/2020
1	Calcitonin Receptor-Like ProteinIBA 01/2018
1	Bone Morphogenetic Protein 4IBA 01/2018
1	PhosphoproteinsIBA 01/2018
1	Adrenergic Agents (Adrenergic Drugs)IBA 08/2017
1	beta-Arrestin 1IBA 08/2017
1	Glucose (Dextrose)FDA LinkGeneric 08/2017
1	ArrestinsIBA 01/2017
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2017
1	Leucine (L-Leucine)FDA Link 01/2017
1	Apelin ReceptorsIBA 01/2017
1	ArrestinIBA 02/2016
1	Phencyclidine (Angel Dust)IBA 02/2016
1	Ouabain (G Strophanthin)IBA 02/2015
1	cariprazineIBA 02/2015
1	Histidine (L-Histidine)FDA Link 01/2015
1	Ghrelin ReceptorsIBA 11/2014
1	GhrelinIBA 11/2014
1	Cocaine (Cocaine HCl)IBA 09/2014
1	Smoothened ReceptorIBA 07/2014
1	Sucrose (Saccharose)IBA 02/2014

Therapy/Procedure

6	Therapeutics 11/2020 - 01/2009
2	Analgesia 05/2013 - 12/2002
2	Ligation 02/2011 - 05/2004
1	Self Administration (Administration, Self) 12/2022
1	Drug Therapy (Chemotherapy) 01/2015